Kyung Nam Pharm suspends M&A process for open sale

Published: 2018-07-04 10:04:23

Updated: 2018-07-04 10:04:23

Kyung Nam Pharm gave a suspension notice of the M&A process for open sale on the 29^th. Thus, they will face a new era with the open sale that they have carried out for transparency in managing the company after suspension of transaction.

Kyung Nam Pharm has been suspended with transaction since 2 March 2018 for the Fraud and Capital Market Act in 2008 and have received a time to improve by 14 ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.